GeneDx Holdings Corp.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-21.0M | $-52.3M | $-175.8M | $-549.0M | $-245.4M | $-241.3M | $-29.7M |
| Depreciation & Amortization | $9.6M | $7.9M | $19.7M | $50.0M | $21.8M | $11.7M | $6.4M |
| Depreciation | $9.6M | $7.9M | $19.7M | $50.0M | $21.8M | $11.7M | — |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $32.2M | $9.1M | $-326.0K | $42.0M | $219.4M | $120.2M | $5.5M |
| Net Cash from Operating Activities | $33.3M | $-28.5M | $-180.1M | $-319.2M | $-190.4M | $-93.1M | $-18.7M |
| Investing Activities | |||||||
| Capital Expenditures | $19.0M | $5.5M | $5.3M | $7.2M | $9.4M | $24.1M | $11.9M |
| Business Acquisitions | — | $0 | $12.1M | $127.0M | $0 | $0 | — |
| Net Cash from Investing Activities | $-61.5M | $-30.1M | $-43.7M | $-141.3M | $-20.8M | $-32.0M | $-15.5M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $48.0M | $44.2M | $186.2M | $197.3M | $493.7M | $129.1M | $148.0M |
| Net Change in Cash | $19.8M | $-14.5M | $-37.6M | $-263.2M | $282.5M | $4.0M | $113.8M |
| Free Cash Flow | $14.3M | $-34.0M | $-185.4M | $-326.3M | $-199.8M | $-117.2M | $-30.7M |